Rocket Doctor AI Raises C$5.2 Million to Fuel AI-Driven Digital Health Expansion

An announcement from Rocket Doctor AI ( (TSE:AIDR) ) is now available.

Rocket Doctor AI Inc. has closed a non-brokered private placement of 7,428,571 units at C$0.70 per unit, raising approximately C$5.2 million, with each unit comprising one common share and one warrant exercisable at C$0.85 until January 22, 2027. Completed under the listed issuer financing exemption, the offering involves freely tradable securities in Canada, included finder commissions and warrants, and will fund digital marketing and customer acquisition, operating and administrative costs, research and development and general working capital, supporting the company’s efforts to scale operations and accelerate its U.S. growth strategy while reinforcing its position in the competitive AI-driven digital health space.

The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.76 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.

Spark’s Take on TSE:AIDR Stock

According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.

The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.

To see Spark’s full report on TSE:AIDR stock, click here.

More about Rocket Doctor AI

Rocket Doctor AI Inc. is a digital health and medical AI company that delivers physician-built, AI-powered solutions to make high-quality healthcare accessible across the entire patient journey. Its core technology includes the Global Library of Medicine, a clinically validated decision-support system developed with input from hundreds of physicians worldwide, and the Rocket Doctor digital health platform and marketplace, which has enabled over 300 doctors to conduct more than 700,000 patient visits via virtual or hybrid practices. The company focuses on improving efficiency and physician autonomy while expanding access to care, particularly for underserved, rural and remote communities in Canada and patients on Medicaid and Medicare in the United States, using advanced AI, large language models and connected medical devices.

Average Trading Volume: 224,937

Technical Sentiment Signal: Buy

Current Market Cap: C$65.43M

For detailed information about AIDR stock, go to TipRanks’ Stock Analysis page.